Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Titan Medical Inc. (T:TMD)

Business Focus: Biotechnology & Medical Research

INK Edge Outlook

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for TMD within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Jan 11, 2021 15:17 ET
Titan Medical Announces Filing of Preliminary Short Form Prospectus
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced today that it has filed a preliminary short form prospectus with applicable securities regulators
Read full article
Jan 05, 2021 16:24 ET
Titan Medical Announces US$10 Million Bought Deal Offering
Titan Medical Inc. (“Titan” or the “Company”) (TSX: TMD) (Nasdaq: TMDI), a medical device company focused on the design and development of surgical technologies for robotic single access surgery, announced it has entered into an agreement with Bloom Burton Securities Inc. (the “Underwriter
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
4.86
--
--
Price to Sales - TTM
13.50
15.50
12.51
Price to Book - most recent quarter
36.02
5.36
4.00
Price to Cash Flow per share - TTM
--
5.72
16.26
Price to Free Cash Flow per share - TTM
--
31.85
27.60
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Dec 31, 2020280,79027,626
Dec 15, 2020253,164-214,008
Nov 30, 2020467,17242,162
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

Titan Medical Inc. is focused on the development of computer-assisted robotic surgical technologies for application in minimally invasive surgery (MIS) comprising its single-port robotic surgical system. The system under development includes a surgeon-controlled patient cart that includes a three dimension (3D) high definition vision system and multi-articulating instruments for performing MIS procedures and a surgeon workstation that provides the surgeon with an ergonomic interface to the patient cart and a 3D endoscopic view inside the patient's body during MIS procedures. It is developing its SPORT Surgical system as a versatile single incision advanced robotic surgical system that features multi-articulated instruments with single-use replaceable tips. It also features visualization on a flat-screen monitor and a single-arm mobile patient cart while enabling broad applications of a single and multi-quadrant surgeries.

See business summary

 

Twitter

Search (past week) for $TMD.CA

  • No tweets found